Schwartzstein, Joshua R. →

Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them

Diversifying clinical trials could build trust in new treatments among Black people and their physicians. Research by Joshua Schwartzstein, Marcella Alsan, and colleagues probes the ripple effects of underrepresentation in testing, and offers a call to action for drugmakers.

Using Models to Persuade

“Model persuasion” happens when would-be persuaders offer receivers a streamlined way of understanding data they already know, especially when the data is open to interpretation. Using examples from finance, politics, and law, the authors find that truthtellers do not eliminate the impact of misleading persuasion because wrong models may better fit the past than correct models.

Channeled Attention and Stable Errors

As humans we are surprisingly good at neglecting unexpected information that conflicts with what we “know” to be true. This paper develops a framework for predicting when we are more likely to “get a clue” despite this cognitive barrier to discovering our own mistakes.

Can Consumers Be Saved From Their Misguided Decisions?

Even with a world of information at our fingertips, consumers routinely make bad decisions on everything from investments to health coverage. Can science help? Research by Joshua Schwartzstein and Benjamin Handel. Open for comment; 0 Comments.